Afinitor Disperz 3 mg (Everolimus TABLET FOR SUSPENSION) 3 MG

AFINITOR DISPERZ 3 MG is an oral tablet for suspension containing everolimus, used for various medical conditions. This medication is designed to provide targeted therapy and is available in a 3 mg strength.

Strength

3 MG

Pack Size

Manufacturer / TM Owner

NOVARTIS PHARMACEUTICALS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

AFINITOR DISPERZ 3 MG is primarily used in the management of certain types of cancer and other medical conditions. It works by inhibiting specific proteins that can contribute to the growth of abnormal cells. This medication is often prescribed for conditions where targeted therapy is beneficial, such as certain types of tumors. What is AFINITOR DISPERZ used for? It is commonly used in the treatment of advanced renal cell carcinoma and other conditions as determined by a healthcare provider.

Side Effects

Common effects of AFINITOR DISPERZ 3 MG may include fatigue, nausea, and mouth sores. Some individuals may also experience changes in their blood cell counts or blood sugar levels. It is important to monitor for any unusual symptoms and consult a healthcare provider if they occur.

Precautions & Warnings

AFINITOR DISPERZ 3 MG should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare provider. This medication may interact with other drugs, so it is crucial to inform your healthcare provider about all medications you are taking.

Avoid Interactions

AFINITOR DISPERZ 3 MG may interact with certain medications, including those that affect the liver's ability to metabolize drugs. It is important to avoid grapefruit and grapefruit juice, as they can interfere with the metabolism of everolimus. Always consult a healthcare provider before starting or stopping any medication.

Frequently Asked Questions

AFINITOR DISPERZ 3 MG is used in the treatment of certain types of cancer and other medical conditions where targeted therapy is beneficial.

AFINITOR DISPERZ 3 MG is an oral tablet for suspension that should be taken as directed by a healthcare provider.

Common side effects may include fatigue, nausea, and mouth sores. Always consult a healthcare provider for personalized advice.

AFINITOR DISPERZ 3 MG may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Precautions include following the prescribed dosage, avoiding grapefruit and grapefruit juice, and monitoring for any unusual symptoms.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.